Breaking News Instant updates and real-time market news.

VRX

Ticker changed BHC

$23.40

-0.84 (-3.47%)

, HLF

Herbalife Nutrition

$53.95

-0.14 (-0.26%)

12:16
07/14/18
07/14
12:16
07/14/18
12:16

Ackman might be making a comeback, Barron's says

Bill Ackman's Pershing Square Holdings has been battered by a long position in Valeant Pharmaceuticals International (VRX) and a short bet against Herbalife Nutrition (HLF), which have been both closed out, Andrew Bary writes in this week's edition of Barron's. But after a humbling three year stretch, the hedge fund titan could be making a comeback, he adds. Closed-end funds tied to Ackman's and Daniel Loeb's hedge funds offer investors an opportunity to participate in their success, Barron's notes. Reference Link

VRX

Ticker changed BHC

$23.40

-0.84 (-3.47%)

HLF

Herbalife Nutrition

$53.95

-0.14 (-0.26%)

  • 01

    Aug

  • 27

    Aug

VRX Ticker changed BHC
$23.40

-0.84 (-3.47%)

06/27/18
RBCM
06/27/18
NO CHANGE
Target $25
RBCM
Sector Perform
Valeant price target raised to $25 from $19 at RBC Capital
RBC Capital analyst Douglas Miehm raised his price target on Valeant to $25, saying the company's FY18 guidance is likely to prove to be "conservative". The analyst notes the management's commentary that Q1 would mark a trough quarter as its fundamentals are improving, adding that Q2 volumes and price trends for Valeant's largest drug - Xifaxan - point to a strong Q2. Miehm keeps his Sector Perform rating however, citing the likelihood of near-term volatility around the potential delays in its Duobrii psoriasis treatment.
06/28/18
DBAB
06/28/18
NO CHANGE
DBAB
Buy
Deutsche reiterates Buy on Valeant after headquarter visit
Deutsche Bank analyst Gregg Gilbert reiterates a Buy rating on Valeant Pharmaceuticals after visiting the company's headquarters. The analyst left feeling that management is doing the right things to strengthen the business, including investing behind core growth franchises, investing in R&D to support future growth, and strengthening the balance sheet. While keeping his estimates unchanged, Gilbert is more confident in potential drivers of upside, including the growth and durability of the Xifaxan franchise and growth for the Consumer and Bausch and Lomb segments. He continues to like the stock's risk/reward.
06/29/18
MZHO
06/29/18
NO CHANGE
Target $31
MZHO
Buy
Valeant price target raised to $31 from $27 at Mizuho
Mizuho analyst Irina Koffler raised her price target for Valeant Pharmaceuticals to $31 to reflect higher Xifaxan estimates. The analyst views the Xifaxan franchise, and not Valeant's dermatology portfolio, as the key growth driver for the company. She reiterates a Buy rating on Valeant shares.
07/13/18
EVER
07/13/18
NO CHANGE
EVER
In Line
Evercore says FDA tentatively approves generic of another top 10 Valeant drug
Evercore ISI analyst Umer Raffat notes that the FDA website shows that a generic version of Valeant's (VRX) Apriso, a top 10 product for the company, has been granted a tentative approval. This approval, which was granted to Teva (TEVA), is the second generic approval for one of the company's top 10 products in the last few days, as a generic Uceris approval was also recently granted, added Raffat in his note to investors. He maintains an In Line rating on Valeant shares.
HLF Herbalife Nutrition
$53.95

-0.14 (-0.26%)

03/05/18
SBSH
03/05/18
UPGRADE
SBSH
Buy
Herbalife Nutrition upgraded to Buy from Neutral at Citi
03/06/18
SBSH
03/06/18
UPGRADE
Target $114
SBSH
Buy
Citi sees further upside in Herbalife, upgrades shares to Buy
Citi analyst Beth Kite last night upgraded Herbalife to Buy from Neutral and raised her price target for the shares to $114 from $85. The stock in premarket trading is up 3%, or $2.98, to $97.25. Since January, the company has made capital allocation announcements, enacted several executive changes, and found out that Bill Ackman closed out his long-standing and well-publicized short position, Kite tells investors in a research note. The analyst sees further upside in the shares as Herbalife executes a tender offer and refinances its debt, to both reinvest in the business and repurchase shares in 2019. If the company can deliver its local currency sales growth guidance in 2018, it would be one of the best top line stories in Household/Personal Care Products, Kite contends.
03/06/18
03/06/18
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. UPS (UPS) upgraded to Buy from Hold at Stifel with analyst David Ross saying after the recent share pullback, UPS' valuation is "reasonable" considering the risks ahead and the increased capital investments expected over the next several years. 2. PPL Corp. (PPL) upgraded to Outperform from Sector Perform at RBC Capital with analyst Shelby Tucker saying he believes that the uncertainty around the impact of RIIO-2 price controls on the company's financials has been more than discounted in the stock price, while the equity needs due to tax reform have also been digested by investors. 3. First Republic (FRC) upgraded to Overweight from Equal Weight at Barclays with analyst Matthew Keating saying he believes the impact of First Republic's "millennial strategies" on client household acquisition is underappreciated and that tax reform will not weigh the bank's businesses. 4. Herbalife Nutrition (HLF) upgraded to Buy from Neutral at Citi with analyst Beth Kite saying since January, the company has made capital allocation announcements, enacted several executive changes, and found out that Bill Ackman closed out his long-standing and well-publicized short position. 5. Mylan (MYL) upgraded to Overweight from Equal Weight at Morgan Stanley. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
05/04/18
RHCO
05/04/18
NO CHANGE
Target $105
RHCO
Hold
Herbalife Nutrition price target raised to $105 from $76 at SunTrust
SunTrust analyst Michael Swartz raised his price target on Herbalife to $105 following its Q1 earnings beat that also showed "improving trends in the U.S." The analyst notes however that China volume fell dramatically by 23% after last year's price increase. Swartz keeps his Hold rating on Herbalife and recommends that investors don't chase the stock price after its year-to-date gains.

TODAY'S FREE FLY STORIES

EXPI

eXp World Holdings

$15.80

-0.035 (-0.22%)

, RDFN

Redfin

$18.07

0.87 (5.06%)

09:25
08/21/18
08/21
09:25
08/21/18
09:25
Conference/Events
Stephens real estate services analyst to hold analyst/industry conference call »

Real Estate Services…

EXPI

eXp World Holdings

$15.80

-0.035 (-0.22%)

RDFN

Redfin

$18.07

0.87 (5.06%)

RLGY

Realogy

$21.30

0.055 (0.26%)

RMAX

RE/MAX Holdings

$48.80

-0.1 (-0.20%)

Z

Zillow

$47.98

1.7 (3.67%)

ZG

Zillow

$47.88

1.69 (3.66%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Sep

  • 06

    Sep

  • 12

    Sep

  • 06

    Nov

CSFL

CenterState Banks

$30.36

0.07 (0.23%)

, CHFN

Charter Financial

$24.50

0.07 (0.29%)

09:25
08/21/18
08/21
09:25
08/21/18
09:25
Conference/Events
Charter Financial to host special shareholder meeting »

Special Shareholder…

CSFL

CenterState Banks

$30.36

0.07 (0.23%)

CHFN

Charter Financial

$24.50

0.07 (0.29%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Aug

  • 24

    Sep

TSLA

Tesla

$308.50

3.17 (1.04%)

, FB

Facebook

$172.50

-1.28 (-0.74%)

09:24
08/21/18
08/21
09:24
08/21/18
09:24
Periodicals
Tesla CEO Musk's Instagram account disappears, Business Insider reports »

Tesla CEO Elon…

TSLA

Tesla

$308.50

3.17 (1.04%)

FB

Facebook

$172.50

-1.28 (-0.74%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Aug

  • 22

    Aug

  • 06

    Sep

  • 18

    Sep

  • 29

    Oct

KSS

Kohl's

$78.86

2.43 (3.18%)

, NKE

Nike

$82.16

2.43 (3.05%)

09:22
08/21/18
08/21
09:22
08/21/18
09:22
Hot Stocks
Kohl's continues to expect CapEx of approx. $700M for FY18 »

CEO Michelle Gass says…

KSS

Kohl's

$78.86

2.43 (3.18%)

NKE

Nike

$82.16

2.43 (3.05%)

UA

Under Armour

$19.45

0.53 (2.80%)

UAA

Under Armour

$21.23

0.735 (3.59%)

ADDYY

Adidas

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Aug

  • 12

    Sep

WLTW

Willis Towers Watson

$148.02

-0.85 (-0.57%)

09:22
08/21/18
08/21
09:22
08/21/18
09:22
Conference/Events
Willis Towers Watson management to meet with SunTrust »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Aug

  • 22

    Aug

  • 05

    Sep

KEYW

KEYW

$7.74

0.02 (0.26%)

09:19
08/21/18
08/21
09:19
08/21/18
09:19
Hot Stocks
KEYW receives contract award worth over $100M »

KEYW announced that it…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Aug

NOV

National Oilwell

$44.16

0.33 (0.75%)

09:18
08/21/18
08/21
09:18
08/21/18
09:18
Upgrade
National Oilwell rating change  »

National Oilwell upgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Sep

  • 26

    Oct

SPX

S&P 500

$0.00

(0.00%)

, VIX

Volatility Index S&P 500 Options

$0.00

(0.00%)

09:18
08/21/18
08/21
09:18
08/21/18
09:18
Options
Overnight activity included 126 trades in SPX and 10 trades in VIX »

126 trades were executed…

SPX

S&P 500

$0.00

(0.00%)

VIX

Volatility Index S&P 500 Options

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WMT

Walmart

$95.99

-1.9 (-1.94%)

09:17
08/21/18
08/21
09:17
08/21/18
09:17
Recommendations
Walmart analyst commentary  »

MKM Partners lowers…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AGS

PlayAGS

$30.84

-0.01 (-0.03%)

09:17
08/21/18
08/21
09:17
08/21/18
09:17
Hot Stocks
PlayAGS to provide its Social White-Label Casino to PokerStars Play »

PlayAGS announced that it…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Sep

09:16
08/21/18
08/21
09:16
08/21/18
09:16
Conference/Events
Stephens healthcare analysts to hold an analyst/industry conference call »

Medical Devices Analyst…

BAH

Booz Allen

$49.85

0.11 (0.22%)

09:14
08/21/18
08/21
09:14
08/21/18
09:14
Hot Stocks
Booz Allen awarded $1.03B task order as prime contractor by DHS »

The Department of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AXS

Axis Capital

$56.56

0.4 (0.71%)

09:13
08/21/18
08/21
09:13
08/21/18
09:13
Hot Stocks
AXIS names Linda Ventresca chief strategy officer »

AXIS Capital Holdings…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Sep

DAVA

Endava

$27.52

-0.63 (-2.24%)

09:13
08/21/18
08/21
09:13
08/21/18
09:13
Initiation
Endava initiated  »

Endava initiated with an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ADUS

Addus HomeCare

$59.90

0.05 (0.08%)

09:12
08/21/18
08/21
09:12
08/21/18
09:12
Initiation
Addus HomeCare initiated  »

Addus HomeCare initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LMT

Lockheed Martin

$324.14

-0.98 (-0.30%)

09:12
08/21/18
08/21
09:12
08/21/18
09:12
Hot Stocks
Lockheed Martin announces GPS III SV02 is available for launch »

As the first Lockheed…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ITB

iShares U.S. Home Construction ETF

$37.48

0.13 (0.35%)

09:12
08/21/18
08/21
09:12
08/21/18
09:12
Technical Analysis
Technical Take: iShares U.S. Home Construction ETF may break out »

The iShares U.S. Home…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MARA

Marathon Patent Group

$0.87

-0.0231 (-2.58%)

09:11
08/21/18
08/21
09:11
08/21/18
09:11
Hot Stocks
Marathon Patent Group regains NASDAQ compliance »

Marathon Patent Group…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NFLX

Netflix

$327.75

10.97 (3.46%)

09:10
08/21/18
08/21
09:10
08/21/18
09:10
Recommendations
Netflix analyst commentary  »

Netflix setup for 2H18…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Aug

CTSO

CytoSorbents

$11.83

0.225 (1.94%)

09:10
08/21/18
08/21
09:10
08/21/18
09:10
Hot Stocks
CytoSorbents awarded $3M funding by NHLBI »

CytoSorbents announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Sep

09:10
08/21/18
08/21
09:10
08/21/18
09:10
General news
U.S. equities resumed their firmer path »

U.S. equities resumed…

09:10
08/21/18
08/21
09:10
08/21/18
09:10
General news
FX Action: USD-CAD »

FX Action: USD-CAD traded…

SSNLF

Samsung

$0.00

(0.00%)

, GOOG

Alphabet

$1,207.54

7.75 (0.65%)

09:09
08/21/18
08/21
09:09
08/21/18
09:09
Conference/Events
FedScoop to hold a forum »

8th Annual FedTalks Forum…

SSNLF

Samsung

$0.00

(0.00%)

GOOG

Alphabet

$1,207.54

7.75 (0.65%)

CRM

Salesforce

$145.68

0.67 (0.46%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Aug

  • 21

    Aug

  • 21

    Aug

  • 22

    Aug

  • 29

    Aug

  • 06

    Sep

  • 07

    Sep

  • 10

    Sep

  • 18

    Sep

  • 20

    Sep

  • 24

    Sep

  • 25

    Sep

  • 28

    Oct

ASUR

Asure Software

$13.26

-0.01 (-0.08%)

09:08
08/21/18
08/21
09:08
08/21/18
09:08
Hot Stocks
Asure Software achieves "In Process" status with FedRAMP »

Asure Software announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Aug

  • 06

    Sep

  • 06

    Sep

  • 07

    Sep

  • 13

    Sep

  • 27

    Sep

KSS

Kohl's

$78.86

2.43 (3.18%)

, TJX

TJX

$101.68

1.33 (1.33%)

09:08
08/21/18
08/21
09:08
08/21/18
09:08
Hot Stocks
Fly Intel: Pre-market Movers »

UP AFTER EARNINGS:…

KSS

Kohl's

$78.86

2.43 (3.18%)

TJX

TJX

$101.68

1.33 (1.33%)

AMTD

TD Ameritrade

$60.16

0.76 (1.28%)

SCHW

Charles Schwab

$51.43

0.52 (1.02%)

ETFC

E-Trade

$61.24

0.09 (0.15%)

JPM

JPMorgan

$114.62

-0.13 (-0.11%)

HPE

HP Enterprise

$16.71

0.05 (0.30%)

TLRY

Tilray

$35.91

5.2 (16.93%)

VTL

Vital Therapies

$9.00

(0.00%)

LEN

Lennar

$51.11

0.55 (1.09%)

DHI

D.R. Horton

$44.80

0.42 (0.95%)

TOL

Toll Brothers

$34.72

0.33 (0.96%)

MDT

Medtronic

$90.06

-0.54 (-0.60%)

FN

Fabrinet

$44.00

0.365 (0.84%)

COTY

Coty

$12.41

0.19 (1.55%)

JILL

J.Jill

$7.62

-0.67 (-8.08%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Aug

  • 21

    Aug

  • 21

    Aug

  • 21

    Aug

  • 21

    Aug

  • 21

    Aug

  • 23

    Aug

  • 28

    Aug

  • 28

    Aug

  • 04

    Sep

  • 05

    Sep

  • 12

    Sep

  • 12

    Sep

  • 12

    Oct

  • 26

    Feb

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.